SightfileU.S. market data from official filings
Companies › ANL
ADLAI NORTYE LTD (ANL)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001944552 · EDGAR filings · Updated 2026-07-20
ADLAI NORTYE LTD (ANL) has 26 institutional managers reporting positions valued at $80.2M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Institutional managers
26
Reported 13F value
$80.2M
Data flags
1 active
from SEC filings
Latest updates
- 2026-07-20 — Prospectus supplement (424B7) filed
- 2026-07-17 — Foreign issuer report (6-K) filed
- 2026-07-15 — Initial insider ownership filed (Form 3)
- 2026-06-10 — Insider transaction reported (Form 4)
- 2026-06-01 — Initial insider ownership filed (Form 3)
- 2026-05-28 — Initial insider ownership filed (Form 3)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ADLAI NORTYE LTD has 26 institutional holders.
Data flags from SEC filings
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2025-05-12 (recurring since 2025-04-30) — source filing. The authoritative details are those stated in the filing itself.
Related companies
TRISALUS LIFE SCIENCES (TLSI) · EQUILLIUM INC (EQ) · GOSSAMER BIO INC (GOSS) · DIAMEDICA THERAPEUTICS INC (DMAC) · STEREOTAXIS INC (STXS) · PROMIS NEUROSCIENCES INC (PMN)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.